TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | -2 | -2 | -4 | -11 | -6 | -19 | -7 |
| S | %wins | 75 | 50 | 75 | 100 | 75 | 100 | 79 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/16/13 18:00 | 8/14/13 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Akirov Alfred | L3 | D | S.m | -568 | 5.05 | 1 | -112 | -2 | 4,915 | I | 9 | -10 | -14 | -3 | -1 | -7 | -7 | 0 | 1 | 2 | -9 | -12 | -5 | -46 | |
3/14/13 19:00 | 3/12/13 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Akirov Alfred | L3 | D | S | -57 | 5.70 | 1 | -10 | 0 | 5,028 | I | -10 | 1 | 7 | 1 | 11 | -3 | -1 | -5 | -2 | 1 | 1 | -8 | 1 | -7 | |
3/12/13 18:30 | 3/8/13 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Akirov Alfred | L3 | D | S.m | -204 | 5.79 | 1 | -35 | -1 | 5,038 | I | -10 | 6 | 13 | 4 | 11 | -2 | 0 | 1 | -2 | -5 | -2 | -10 | -7 | -10 | |
3/8/13 17:04 | 3/6/13 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Akirov Alfred | L3 | D | S.m | -75 | 5.71 | 1 | -13 | 0 | 5,073 | I | -13 | 5 | 5 | 4 | 10 | -3 | -2 | 1 | -3 | -6 | -6 | -14 | -11 | -12 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |